|
NIPSNAP3B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.627040E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.835500E-02 |
| Normal-vs-Stage2 |
4.634000E-01 |
| Normal-vs-Stage3 |
6.508000E-01 |
| Normal-vs-Stage4 |
8.904800E-01 |
| Stage1-vs-Stage2 |
5.648400E-01 |
| Stage1-vs-Stage3 |
1.717980E-01 |
| Stage1-vs-Stage4 |
9.844000E-02 |
| Stage2-vs-Stage3 |
7.038000E-01 |
| Stage2-vs-Stage4 |
4.284800E-01 |
| Stage3-vs-Stage4 |
6.020400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.507200E-01 |
| Normal-vs-AfricanAmerican |
1.606200E-01 |
| Normal-vs-Asian |
1.904340E-02 |
| Caucasian-vs-AfricanAmerican |
2.845600E-01 |
| Caucasian-vs-Asian |
5.524400E-02 |
| AfricanAmerican-vs-Asian |
9.837200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.932300E-02 |
| Normal-vs-Female |
2.656000E-01 |
| Male-vs-Female |
2.874200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.956100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.907390E-01 |
| Normal-vs-Age(61-80Yrs) |
9.343200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.403000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.658000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.589600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.947700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.264000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.055800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.646400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.197010E-01 |
| Classical-VS-Follicular |
1.334400E-01 |
| Classical-VS-Other |
4.514600E-01 |
| Classical-VS-Normal |
4.647600E-02 |
| Tall-VS-Follicular |
6.041200E-01 |
| Tall-VS-Other |
9.922000E-02 |
| Tall-VS-Normal |
8.361400E-01 |
| Follicular-VS-Other |
2.356200E-01 |
| Follicular-VS-Normal |
6.613800E-01 |
| Other-VS-Normal |
9.560400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.934600E-01 |
| Normal-vs-N1 |
1.114240E-01 |
| N0-vs-N1 |
1.747200E-01 |
|
|
